Medical Supplies and Services News

Déclaration de transactions sur actions propres Paris, France (9 mars 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que du...

Disclosure of transactions in own shares Paris, France (March 9, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025,...

ALLENTOWN, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine is helping address the national shortage of clinical laboratory professionals through its Career Connections program, a hands-on...

HIGHLIGHTS Amplia’s lead drug narmafotinib enhances the activity of kRAS inhibitors in multiple preclinical cancer models presented at US conferenceData showing narmafotinib activity in preclinical...

Human Appeal has been running its inaugural winter clothing collections for 10 years in a row, celebrating an increase of over 60% in donations.

Se venligst vedlagte pdf.   Vedhæftet fil 08032026_handel_med_aktier_GL ...

Please see enclosed pdf.   Attachment 08032026_trading_in_shares_GL ...

Deposito del Documento di registrazione universale 2025 Parigi, Francia (6 marzo 2026) - EssilorLuxottica annuncia la messa a disposizione del suo Documento di registrazione universale 2025 secondo...

Mise à disposition du Document d’enregistrement universel 2025 Paris, France (6 mars 2026) – EssilorLuxottica annonce la mise à disposition de son Document d’enregistrement universel 2025 dans les...

2025 Universal Registration Document filed Paris, France (6 March 2026) – EssilorLuxottica announces the availability of its 2025 Universal Registration Document, in accordance with applicable...